Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID2176 | KGPGPGGPGGAGVARGGAGGGP | Neurogranin | Serum | 1686.85501 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID2177 | GGPGGAGVARGGAGGGP | Neurogranin | Serum | 1250.6116 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID9852 | GGPGGAGVARGGAGGGP | Neurogranin | Serum | 626.31 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9853 | KGPGPGGPGGAGVARGGAGGGP | Neurogranin | Serum | 563.31 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID12753 | GGPGGAGVARGGAGGGP | Neurogranin | Serum | 1251.732 | MALDI-TOF | Breast cancer | "Upregulated with the fold change of 1.16 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.07, Upregulated in BC vs healthy with 1.103 fold change" | 27058005 |